deltatrials
Completed PHASE4 NCT01472692

Study of Febuxostat Effect on Blood Pressure in Patients With High Normal Blood Pressure

Treatment of Uric Acid With the Xanthine Oxidase Inhibitor Febuxostat: Effects on Blood Pressure, Metabolic Markers, and Aortic Stiffness in Prehypertensive

Sponsor: University of California, San Diego

Conditions 24 Hour Blood Pressure Gout Hypertension Prehypertension Pulse Wave Velocity
Interventions Febuxostat
Updated 10 times since 2017 Last updated: Nov 26, 2019 Started: Oct 31, 2011 Primary completion: Mar 31, 2014 Completion: Mar 31, 2014

A PHASE4 clinical study on 24 Hour Blood Pressure and Gout, this trial is completed. The trial is conducted by University of California, San Diego and has accumulated 10 data snapshots since 2011. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.

Change History

10 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE4

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  3. Jan 2023 — Jul 2024 [monthly]

    Completed PHASE4

  4. Dec 2022 — Jan 2023 [monthly]

    Completed PHASE4

  5. Dec 2021 — Dec 2022 [monthly]

    Completed PHASE4

▶ Show 5 earlier versions

  1. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE4

  2. Jan 2020 — Jan 2021 [monthly]

    Completed PHASE4

  3. Jun 2018 — Jan 2020 [monthly]

    Completed PHASE4

  4. Feb 2017 — Jun 2018 [monthly]

    Completed PHASE4

  5. Jan 2017 — Feb 2017 [monthly]

    Completed PHASE4

    First recorded

Oct 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • University of California, San Diego
Data source: University of California, San Diego

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

  • • San Diego, United States